Seattle Genetics Achieves Milestones Under Collaboration with Takeda for Achieving First Commercial Sales of ADCETRIS
April 08, 2014 at 09:02 AM EDT
Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that it will receive milestone payments from Takeda Pharmaceutical Company ...